SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Emmaus Life Sciences, Inc. – ‘10-K’ for 9/30/17

On:  Friday, 12/29/17, at 3:46pm ET   ·   For:  9/30/17   ·   Accession #:  1615774-17-7691   ·   File #:  1-35527

Previous ‘10-K’:  ‘10-K’ on 12/22/16 for 9/30/16   ·   Next:  ‘10-K’ on 12/11/18 for 9/30/18   ·   Latest:  ‘10-K’ on 3/31/23 for 12/31/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/29/17  Emmaus Life Sciences, Inc.        10-K        9/30/17   71:8.8M                                   S2 Filings LLC/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    987K 
 2: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     17K 
 3: EX-21.1     Subsidiaries List                                   HTML     18K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     19K 
 5: EX-23.2     Consent of Experts or Counsel                       HTML     20K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     21K 
16: R1          Document and Entity Information                     HTML     49K 
17: R2          Consolidated Balance Sheets                         HTML    106K 
18: R3          Consolidated Balance Sheets (Parenthetical)         HTML     44K 
19: R4          Consolidated Statements of Operations               HTML     68K 
20: R5          Consolidated Statements of Changes in               HTML     83K 
                Stockholders' Equity (Deficit)                                   
21: R6          Consolidated Statements of Cash Flows               HTML    112K 
22: R7          Nature of Operations                                HTML     42K 
23: R8          Summary of Significant Accounting Policies          HTML     78K 
24: R9          Convertible Debt and Equity Financings              HTML    151K 
25: R10         Derivative Liabilities                              HTML     52K 
26: R11         Stockholders' Equity                                HTML    239K 
27: R12         Income Taxes                                        HTML     51K 
28: R13         Related Party Transactions                          HTML     63K 
29: R14         Loss Per Share                                      HTML     35K 
30: R15         Commitments and Contingent Liabilities              HTML     39K 
31: R16         Significant Customers                               HTML     23K 
32: R17         Subsequent Events                                   HTML     24K 
33: R18         Summary of Significant Accounting Policies          HTML    138K 
                (Policies)                                                       
34: R19         Summary of Significant Accounting Policies          HTML     25K 
                (Tables)                                                         
35: R20         Convertible Debt and Equity Financings (Tables)     HTML    121K 
36: R21         Derivative Liabilities (Tables)                     HTML     40K 
37: R22         Stockholders' Equity (Tables)                       HTML    184K 
38: R23         Income Taxes (Tables)                               HTML     48K 
39: R24         Related Party Transactions (Tables)                 HTML     40K 
40: R25         Loss Per Share (Tables)                             HTML     34K 
41: R26         Commitments and Contingent Liabilities (Tables)     HTML     29K 
42: R27         Nature of Operations (Details Narrative)            HTML     84K 
43: R28         Summary of Significant Accounting Policies          HTML     26K 
                (Details)                                                        
44: R29         Summary of Significant Accounting Policies          HTML     65K 
                (Details Narrative)                                              
45: R30         Convertible Debt and Equity Financings (Details)    HTML    123K 
46: R31         Convertible Debt and Equity Financings (Details     HTML    185K 
                Narrative)                                                       
47: R32         Derivative Liabilities (Details)                    HTML     56K 
48: R33         Derivative Liabilities (Details Narrative)          HTML     92K 
49: R34         Stockholders' Equity (Details)                      HTML     32K 
50: R35         Stockholders' Equity (Details 1)                    HTML     26K 
51: R36         Stockholders' Equity (Details 2)                    HTML     53K 
52: R37         Stockholders' Equity (Details 3)                    HTML    128K 
53: R38         Stockholders' Equity (Details 4)                    HTML     50K 
54: R39         Stockholders' Equity (Details 5)                    HTML     32K 
55: R40         Stockholders' Equity (Details 6)                    HTML     42K 
56: R41         Stockholders' Equity (Details 7)                    HTML     57K 
57: R42         Stockholders' Equity (Details Narrative)            HTML    611K 
58: R43         Stockholders' Equity (Details Narrative 1)          HTML     48K 
59: R44         Income Taxes (Details)                              HTML     40K 
60: R45         Income Taxes (Details 1)                            HTML     39K 
61: R46         Income Taxes (Details Narrative)                    HTML     25K 
62: R47         Related Party Transactions (Details)                HTML     53K 
63: R48         Related Party Transactions (Details Narrative)      HTML    147K 
64: R49         Loss Per Share (Details)                            HTML     41K 
65: R50         Commitments and Contingent Liabilities (Details)    HTML     42K 
66: R51         Commitments and Contingent Liabilities (Details     HTML     83K 
                Narrative)                                                       
67: R52         Significant Customers (Details Narrative)           HTML     29K 
68: R53         Subsequent Events (Details Narrative)               HTML     36K 
70: XML         IDEA XML File -- Filing Summary                      XML    119K 
69: EXCEL       IDEA Workbook of Financial Reports                  XLSX    105K 
10: EX-101.INS  XBRL Instance -- myan-20170930                       XML   2.60M 
12: EX-101.CAL  XBRL Calculations -- myan-20170930_cal               XML    151K 
13: EX-101.DEF  XBRL Definitions -- myan-20170930_def                XML    843K 
14: EX-101.LAB  XBRL Labels -- myan-20170930_lab                     XML   1.24M 
15: EX-101.PRE  XBRL Presentations -- myan-20170930_pre              XML   1.05M 
11: EX-101.SCH  XBRL Schema -- myan-20170930                         XSD    194K 
71: ZIP         XBRL Zipped Folder -- 0001615774-17-007691-xbrl      Zip    195K 




        
Filing Submission 0001615774-17-007691 – SGML Text

Original SGML Text submitted by:  S2 Filings LLC/FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 6:51:19.2pm ET